RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease

SCHENKMAN M; ELLIS T; CHRISTIANSEN P; BARON AE; TICKLE DEGNEN L; HALL DA; WAGENAAR R
PHYS THER , 2011, vol. 91, n° 9, p. 1339-1354
Doc n°: 153802
Localisation : Documentation IRR

D.O.I. : http://dx.doi.org/DOI:10.2522/ptj.20100236
Descripteurs : AF5 - PARKINSON

Overall functional ability declines over time in people with
Parkinson disease (PD). Established benchmarks are needed to allow clinicians and
researchers to facilitate meaningful interpretation of data.
OBJECTIVE: The purposes of this study were: (1) to report typical values for standard measures
of functional ability commonly used in intervention studies and clinical practice
with individuals in the early and middle stages of PD and (2) to describe the
profile of functional limitations using the Hoehn and Yahr (H&Y) stages of
disease and Unified Parkinson's Disease Rating Scale (UPDRS) motor scores.
DESIGN: Cross-sectional data were obtained from 5 different studies. METHODS:
Three hundred thirty-nine patients were evaluated for disease severity (UPDRS
motor score); functional capacity (Continuous Scale Physical Functional
Performance Test [CS-PFP]); balance and gait (Functional Reach Test [FRT], Timed
"Up & Go" Test [TUG], 360-degree turn, Six-Minute Walk Test [6MWT], and
Two-Minute Walk Test); and basic functional activities (supine-to-stand task,
stand-to-supine task, and functional axial rotation [FAR]). RESULTS: The mean
UPDRS motor score for the sample was 39.2 (SD=12.93). At each stage of PD (from
least to most involved), scores on functional measures indicated a significant
and progressively reduced functional status. Limitations began early in the
disease for the CS-PFP and FAR. Losses in performance were consistent across all
stages of disease for the CS-PFP, FRT, 6MWT, and FAR. Several measures
demonstrated meaningful losses of function only in later stages of disease.
Findings extend current appreciation of functional limitations that begin early
in PD and can guide the choice of functional outcome measures at different stages
of disease severity. LIMITATIONS: Data were obtained only from participants in
H&Y stages 1 through 3 and only for some of the performance measures typically
used. CONCLUSIONS: The findings demonstrate that functional loss occurs at
different points in the disease process, depending on the task under
consideration. The resulting profile of functional limitations provides
benchmarks that clinicians and researchers can use to interpret and monitor
status of patients.

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0